█ INTRODUCTION
T emporary or permanent implants are used in stabilization surgeries of the human musculoskeletal system. Stainless steel (SS) alloy (SS 316L) and Titanium (Ti) alloy (Ti6Al4V), which are frequently used biomaterials for such implantations, are considered bio-inert materials.
One of the problems associated with the use of these biomaterials is that there is a possibility for the metal ions to separate from the implant in time and bind to biomolecules. Therefore, regardless of the corrosion of the implant, adverse tissue reactions, a promotion of infection, metal sensitivity, metal accumulation in the organs, and even possible cytotoxic effects have been reported (6, 7, 9, 17) . █ 
MATERIAL and METHODS

Experimental Animals and Metallic Implants
The ethics committee approval for animal studies has been obtained from the Local Ethics Board for Animal Studies at the Istanbul University, as resolution Number 2013/26.
In the study, 39 Wistar albino male rats of 250-300 gram were randomly numbered and divided into 3 groups (n=13 each). Group I was the sham surgery group, Group II was the Ti (Ti6AI4V) alloy rod group and Group III was the SS (SS 316L) alloy rod group.
Anesthetic agents ketamine (50 mg/kg) and xylazine (10 mg/kg) were administered intraperitoneally to each rat. Postanesthesia, the animals were placed on the operating table in the prone position. Prophylactic antibiotics were given intramuscularly before the surgery. At the thoracolumbar region, a 2 cm midline incision was made and the paravertebral region down to the lamina-facet junction was exposed by blunt dissection. No implant was used in Group I (the sham group). Rods were implanted on the lamina in Group II and III. The fascia and cutaneous tissue were closed with a 3/0 nonabsorbable suture.
Environmental conditions such as temperature (25±2°C), light (12 hours light/dark), humidity (50-70%) and ventilation of the room the animals were accommodated during the experiment were in compliance with relevant standards with automated lighting, an air conditioning device and ventilation system. Throughout the experiment, all rats were kept in polycarbonate cages, with a maximum of four animals per cage, and 250 cm 2 of space per animal. All animals were fed with standard rat food ad-libitum.
The animals were monitored for physiological parameters and behavior throughout the experiment. The experiment was discontinued in case of a pathological change in physiological parameters or behavior of the animals. The subjects were also followed up for clinical symptoms including severe dehydration, hypothermia, hyperthermia, cachexia and anorexia. The experiment was terminated with cervical dislocation.
Considering that there might be changes in the immune parameters of female rats during their oestrus cycles, male Wistar albino rats were preferred for the experiment. Peripheral blood samples of approximately 1.5 cc were drawn from all rats in all three groups before the surgery and on Day 7, 14 and 28 after the surgery.
Surgical tools and rods to be used as implants were prepared in 1 cm pieces and sterilized before the surgery.
Immunologic Analysis
CD4, CD8, CD25 (IL-2R), CD4+CD8+ and CD4+CD25+Foxp3+ (Tregs) were measured using the flow cytometry method.
Cytokine Analysis
Interleukins (IL) such as IL-4, IL-10, IL-6, IL-17A, transforming growth factor-β (TGF-β) and tumor necrosis factor-α (TNF-α) were measured using a multiple analyte platform (XMAP, Luminex).
Statistics
Descriptive statistics (mean, standard deviation) were performed to analyze the variables. The groups were compared with a one-way analysis of variance (ANOVA), and the Tukey's honest significant difference (HSD) test (for variables with homogenous variances) was used for the paired comparison of significant variables. The threshold for statistical significance was set at p<0.05.
█ RESULTS
The numerical values of the parameters analyzed in the study and their statistical significance have been presented in Figure  1 and Table I. A schematic diagram has been presented in Figure 2 for a better understanding of the chain of immunologic responses that the biomaterials used in our study triggered.
The CD4+ cell response after SS alloy implantations (Group III) was found to be significantly reduced on Days 14 and 28 when compared to the control group (Group I) and Group II (Ti alloy rod). CD8+cells, on the other hand, which are an indicator of host-implant compatibility, did not present any change in the control or Group II, whereas they showed a tendency to increase in Group III (particularly on Day 14). CD4+ and CD8+ cells did not display any significant changes in Group II or Group III compared to Group I. However, while there was no significant change in the number of CD4+ and CD8+ cells in our study, a cascade might have been triggered because of a combination of signals resulting from an increased number of surface receptors and a stimulation of co-receptor activity, as well as cytokine release. This assumption follows the fact that the functions of T cells and those of their subgroups, as well as cytokine release, were actively triggered in our study.
CD25 (IL-2R) levels in the SS alloy and Group II showed a significant and gradual decrease especially on Days 14 and 28. The decrease was more marked in Group III compared to Group II. CD25 (IL-2R, CD4+) levels in Group III decreased significantly when compared to Group I and Group II. There was no significant difference in CD25 (IL-2R, CD4+) levels between the latter two groups. T cell response was limited due to the decrease in the IL-2R level. Compared to Group I and Group II, CD4+CD8+ levels in Group III decreased significantly, especially on Days 14 and 28. Although there was also a decrease in Group II in CD4+CD8+ levels vis-à-vis Group I, it was not found to be significant. It is known that CD4+CD8+ T cells play role in the formation of a strong specific immune response to inflammation. The reduced CD4+CD8+ level observed in our study shows that the autoimmunity of the host is suppressed.
CD4+/CD25+Foxp3+(Tregs) levels decreased significantly on all days in Group III compared to the control group and Group II. In Group II, on the other hand, there was an increase in comparison with Group I. The increase was significant on Day 14, but was found to abate on Day 28.
We found a significant increase in the TNF-α level in Group III compared to the control and Group II. Group II, however, shows no significant difference in TNF-α level in comparison with Group I (Table I ). This result suggests that there is a more marked pro-inflammatory response in Group III. It is known that inflammatory diseases and tissue damage might occur when Th1 functions cannot be balanced (10) .
█ DISCUSSION
During the immune response following the implantation of a biomaterial, cytokines (pro-and anti-inflammatory mediators) are released as a result of the activation of leukocytes, and together with signaling protein molecules these cytokines coordinate a series of physiological processes such as wound healing, wound repair and immune reactions.
With the activation of macrophages, TNF and many IL cytokines (IL-1, IL-6, IL-8, IL-12, IL-15, IL-18, IL-23) are produced.
In addition to the aforementioned macrophage activation, lymphocytes perform a regulatory function via the Th1 cell and Th2 cell pathways. The Th1-cell response triggers cellmediated immune response with a release of cytokines such as IFN-γ and IL-2, and the Th2-cell response activates B-lymphocytes by releasing cytokines like IL-4 and IL-10, all leading to a humoral immune response (3, 5) . These cytokines are held responsible for infection, debris formation, bone resorption, osteoclast activity and bone remodeling after implantation.
CD4+ cells assume the role of a "conductor" orchestrating the response. Such a decrease in the number of CD4+ cells might cause a reduction in MHC class II molecules, complement receptors, the stimulation of B lymphocytes, and the production of cytokines. In both intracellular and extracellular antigenic structures, these two cell groups control the immune 
IL-2 signals stimulate regulatory T (Treg) cells through IL-2R.
Tregs express a high level of IL-2Rα chains (CD25) and need IL-2 in order to continue developing. A decrease in the IL-2R level might increase affinity to autoimmunity by affecting T cell homeostasis.
CD4+/CD25+Foxp3+ (Tregs) control destructive immune responses against pathogens by preventing the development of an immune response to self-antigens and harmless external antigens in the organism (22) . Thus, self-tolerance develops, protecting the immune system from being overactive and eventually harming endogenous tissues (15, 24) .
The increase in CD4+/CD25+Foxp3+(Tregs) in Group II following implantation controls the development of a destructive immune response by stimulating the peripheral regulatory mechanism. On the other hand, the decrease in the CD4+/ CD25+Foxp3+ (Tregs) level in Group III might trigger a cytotoxic and suppressive immune response, initiating pathological damage. CD4+/CD25+Foxp3+(Tregs) also suppress cytokine production (especially IL-2 production) by CD4+ and CD8+ responder T cells and their effector activities such as CD8+ T cell cytotoxicity.
Following metal implantation, metal ions have been reported to activate the release of various cytokines by coming into contact with peripheral T cells, thereby activating macrophages (15).
TNF-α is a pro-inflammatory cytokine released by macrophages at an early stage and particularly responsible for systemic inflammatory symptoms, such as fever, and for the activation of other cytokines.
IL-6 is a pro-inflammatory cytokine released by T cells and macrophages following infections and traumas. In contrast, there was a significant increase in Group II compared to Group I and Group III. The increase in IL-10 regulates immune effector functions, reduces the expression of inflammatory cytokines and suppresses the proliferation of T cytotoxic cells. Therefore, a possible interpretation is that the antiinflammatory cytokine response associated with IL-4 and IL-10, manifests itself in a more effective way in Group II compared with Group III. The results from this study provide evidence of the possible function of IL-4 and IL-10 in the suppression of Group II particle-induced activation of macrophages. IL-4 may be a useful therapeutic agent in transplantation.
In contrast to Th1 and Th2 cells, the Th17 cell drives major neutrophils and other leukocyte subgroup cells to gather at the inflammation site via proinflammatory cytokines such as IL-6 by causing the release of cytokines like IL-17 (IL-17A) and TNF-α in inflammatory and autoimmune settings (4, 11, 19) . On the other hand, TGF-β and IL-6, as pro-inflammatory cytokines, trigger the continuity of the immunologic response by enabling the differentiation of naive T (Th0) cells towards Th17 (8).
Th17 releases IL-17A pro-inflammatory cytokines. These cytokines cause destructive tissue damage in a delayedtype reaction by monocytes and neutrophils (to reach or as they reach) the sites of inflammation. They play a role in the pathogenesis of autoimmune and acute transplant rejections. In case of extracellular damage, Th17 cells release high amounts of IL-17A and play a significant role in the development of autoimmunity. IL-17A is a pleiotropic cytokine, which mediates tissue inflammation by inducing many pro-inflammatory cytokines such as IL-6 and TNF-α and chemokines (18) .
Ten percent of CD+4 T lymphocytes in the peripheral blood carry IL-2R (CD25) chains, and these cells called Tregs have been found to maintain tolerance against self-antigens by suppressing Th and B lymphocytes (25) . Naive T cells that are exposed to TGF-β, an anti-inflammatory cytokine, induce Treg cells by expressing Foxp3 while IL-6 inhibits the induction of TGF-β-mediated Foxp3+ regulatory cells.
In our study, IL-17A levels in Group III are higher than those in Group I and Group II. Group II, on the other hand, showed a significant decrease compared with Group I. Therefore, it could be argued that the development of destructive tissue damage surrounding a metallic implant was more obvious in Group III vis-à-vis Group II.
IL-1β and TNF-α secretions regulated by IL-17 are suppressed by IL-4 and IL-10 cytokines (21). In our study, it could be argued that the effect of IL-17 on these type of cytokines could be reduced due to the increase of IL-4 and IL-10 levels in Group II compared to the SS alloy (Group III) and control groups.
TGF-β is a protein that controls proliferation and cellular differentiation. Together with Foxp3+Treg, it regulates the immune system. In normal cells, TGF-β stops proliferation by interrupting the cell cycle at the G1 stage. In our study, there was a significant increase in TGF-β levels in the SS alloy and Group II compared to Group I. However, the increase in Group III was found to be more significant than that of Group II. Since CD25 (IL-2R) levels are lower in Group III than in Group II, the increased TGF-β level causes a reduction in activity by suppressing IL-2 production by the T cells.
TGF-β may act as a mediator of suppression as a membranebound form, although this is controversial. It may condition responder T cells to be sensitive to suppression and suppressive activity and might also contribute to the differentiation of other T cells into Treg-like cells that results in infectious tolerance. While Treg cells cause homeostasis, they manifest their immunosuppressive effect in the release of suppressive cytokines such as IL-10 and TGF-β, their consumption of the IL-2 local concentration, which triggers apoptosis and stops the cell cycle at the cell-to-cell contact (13) . Our findings and other findings suggest that Th17 cells and Treg cells balance the immune response together through a mutual antagonist interaction. On the other hand, according to our findings, it could be argued that the enabling of immune homeostasis in Group II is a result of a mutual antagonist interaction of Th17 cells with Treg cells by increasing tolerance in the immune system while producing an immune response that is not excessive and does not harm endogenous tissues. Some studies were shown that titanium implants produce less reaction than stainless steel plates (23) . Other studies have reported infections when stainless steel and titanium implants were used in patients, independently from the material (1, 13, 21) .
In spinal surgery, when comparing Ti alloy and SS implants, only the SS implants cause late onset postoperative infections. Additionally, some degree of tissue loosening and corrosion has been observed (20) . In our study, however, we showed a tendency to inflammation in the subjects that had stainless steel implants. At the same time, the anti-inflammatory parameters that ensure the immune defense system were lower for the stainless steel implants.
█ CONCLUSION
Ti alloy implants suppress the development of inflammation by inhibiting the pro-inflammatory (Th1) response; strengthen the humoral immune system by accentuating the antibodydependent immune response (through a stimulation of B lymphocytes and cytokines that enable the formation of antibodies); trigger the development of immune tolerance by regulating the immune response; and activate the mechanism that prevents the occurrence of immune response-related damage.
SS alloy implants increase the tendency for chronic inflammation and apoptosis; weaken the antibody-dependent immune response; cause fever after implantation (especially through the effect on IL-6 increase and prostaglandins); and trigger the mechanism that increases affinity to autoimmune diseases.
Compared to SS implants, Ti implants prevent possible harmful effects associated with the immune response by keeping immune activity within certain limits.
